ViruSAL is Effective against at least 88% of all Respiratory Viruses*
*Based on In Vitro efficacy against enveloped species
Potent and Rapid Efficacy against SARS-CoV-2
Physiologically Relevant Human Bronchial Epithelial Cells grown in air / liquid Interface culture
Pre-Infection:
ViruSAL treated 1 hour prior to infection No Viable Virus Recoverable
Post-Infection:
ViruSAL Treated 1 hour after infection. No Viable Virus Recoverable